March 4, 2025
Ad Scientiam launches the MS-FLOWER pilot project in the United States to evaluate the integration of MSCopilot® into the daily care of patients with multiple sclerosis, with 100 patients across five U.S. centers.
A promising pilot project for multiple sclerosis!
We are delighted to announce the launch of the MS-FLOWER pilot project in the United States by Ad Scientiam! Our goal? To evaluate the integration of our innovative medical device, MSCopilot®, into the daily care of patients with multiple sclerosis (MS).
Building on our collaboration with Sanofi on the MS-Detect study, which enrolled more than 300 patients in the United States, Canada and Europe, we plan to enroll 100 patients across five U.S. reference centers over the next six months.
Together, let's explore how MSCopilot® can:
- Optimize disease management
- Improve real-time symptom monitoring
- Strengthen the engagement of patients and healthcare professionals